Table 2.
Species | Neurologic Signs | Route of Infection | References | |
---|---|---|---|---|
Human | Clinical | Signs: drowsiness, coma, seizures, convulsions, depression, disorientation, paralysis, encephalitis Sequelae: paralysis, convulsions, somnolence, seizures, coma, confusion, epilepsy, intellectual disability, altered personality, mental incapacity, photophobia, hearing loss, anosmia, ageusia, depression, recurrent headaches, fatigue |
Aerosol or subcutaneous | [14,19,44,45,50] |
Mouse | BALB/c | Succumb prior to neurologic signs | Aerosol or subcutaneous | [52,53,54] |
CD-1 | Hind limb paralysis | Subcutaneous | [33,51,55] | |
CB17 | Paralysis | Subcutaneous | [56] | |
SCID | Severe aggression, ataxia, unresponsiveness to stimuli | Subcutaneous | [56] | |
Hamster | Golden Syrian | Succumb prior to neurologic signs | Aerosol or subcutaneous | [57,58] |
Non-human Primate | Cynomolgus Macaques | Ataxia, fever, depression, tremors, twitching, photophobia, nystagmus, hypothermia | Aerosol | [52,59,60] |
No clinical or neurologic signs | Cutaneous | [42,61] |